USANA Health Sciences Inc
USANA Health Sciences Inc is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Salt Lake City, UT. In its latest annual figures on file, for the fiscal year ended 2026-01-03, it reported revenue of $925 million and a profit of $11 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2833, Medicinal Chemicals & Botanical Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 6.7 out of ten, 9 of 9 metrics filed: past 6.2 out of ten, present 7.3 out of ten, future 6.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 8.3 out of ten. No warning events in its filings since 2017. 83rd percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 3.8 out of ten. -3.5% a year over 8 filed years; profitable in 8 of 8. 38th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 7.9 out of ten. Share count shrank 1.3% a year. 32% of cash flow returned. Insiders: 17 sales, 0 purchases. 79th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 8.5 out of ten. ROE 2%: 2¢ of profit per shareholder dollar. Leverage 28%: owes 28¢ per asset dollar. 85th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 6.7 out of ten. top 33% of 18 in its family; net margin 1.2%. 67th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 6.0 out of ten. top 40% of 12 in its family for leadership; chief executive since 2026. 60th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 6.9 out of ten. top 31% of 18 in its family for room to expand. 69th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 7.0 out of ten. top 30% of 18 in its family for growth drivers. 70th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 4.7 out of ten. bottom 47% of 18 in its family for expectations against reality. 47th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-03-16 for the period ended 2026-01-03 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-13 for the period ended 2026-07-04 (on EDGAR). Newest results release: Form 8-K filed 2026-08-04 (on EDGAR). Newest filing: Form 8-K, 2026-10-05. Filings on record since 1996. Read from EDGAR 2026-10-12.
Where the revenue comes from
By geography: Greater China 46%, United States 24%, Southeast Asia Pacific 14%, North Asia 8%, South Korea 8%. As tagged in its annual report (Form 10-K, filed 2026-03-16).
Who runs it
Guest, Kevin (CEO & EXEC. CHAIRMAN OF BOARD); Wentz, Myron W (CEO); Brown, Jim (CEO & PRESIDENT); Fuller, Gilbert A (CFO and Executive V.P.); Iiekking, G Doug (CHIEF FINANCIAL OFFICER); Noot, Walter (CHIEF OPERATING OFFICER); Armstrong, Kathryn Michelle (CHIEF SCIENTIFIC OFFICER); Benedict, Peter (CHIEF INFORMATION OFFICER); Neidig, Brent (CHIEF COMMERCIAL OFFICER); Jones, Paul A. (CHIEF PEOPLE OFFICER); and 9 more. 19 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.